Movelat Relief Sport (Mucopolysaccharide Polysulfuric Acid Ester, Salicylic Acid)

Mucopolysaccharide Polysulfuric Acid Ester and Salicylic Acid, the active ingredients in Movelat Relief Sport, are presented as a topical formulation for external use. They are intended to help manage common skin conditions such as acne, psoriasis plaques, and hyperkeratotic areas in adults.

GNH USA supplies Movelat Relief Sport as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies worldwide. The product complies with EU quality standards and is distributed under strict Good Distribution Practice guidelines.

Movelat Relief Sport, containing salicylic acid and a mucopolysaccharide ester, is applied topically to address keratinocyte turnover and inflammation in dermatologic conditions.

- Acne vulgaris: reduces follicular blockage and inflammation, helping clear lesions. - Psoriasis plaques: softens scales and promotes desquamation of thickened skin. - Callus/Hyperkeratosis: exfoliates excess keratin, facilitating removal of hardened skin.

Topical application of Movelat Relief Sport may be associated with the following adverse reactions.

Common Side Effects: - Skin irritation - Redness - Dryness - Peeling - Itching - Burning sensation

Serious or Rare Side Effects: - Allergic contact dermatitis - Severe skin ulceration - Systemic salicylate toxicity (rare) - Photosensitivity reaction - Anaphylaxis (rare)

Before using Movelat Relief Sport, consider these precautionary measures.

- Avoid use on open wounds: apply only to intact skin. - Limit application area: do not exceed 10% of body surface per day. - Discontinue if severe irritation occurs: seek medical advice. - Do not combine with other keratolytic agents: may increase irritation. - Pregnant or breastfeeding women: consult a healthcare professional before use. - Store at room temperature: keep in original container, protect from moisture and light.

Movelat Relief Sport can interact with certain medications or topical agents.

Major Interactions (Avoid): - Concurrent use with other topical salicylates: may increase systemic absorption. - Combined application with retinoids: heightened risk of skin irritation.

Moderate Interactions (Monitor Closely): - Oral anticoagulants (e.g., warfarin): potential for increased bleeding risk. - Systemic non‑steroidal anti‑inflammatory drugs: may elevate salicylate levels. - Alcohol consumption: can exacerbate skin irritation.